Personal information

No personal information available

Activities

Employment (1)

Jiangsu Province Center for Disease Control and Prevention: Nanjing, Jiangsu, CN

2010-09-01 to present | Dr. (Vaccine clinical evaluation department)
Employment
Source: Self-asserted source
Jingxin Li

Works (3)

Impact of Immunosenescence on Vaccine Immune Responses and Countermeasures

Vaccines
2024-11 | Journal article | Author
Contributors: Li Chen; Chengwei Shao; Jingxin Li; Fengcai Zhu
Source: check_circle
Multidisciplinary Digital Publishing Institute

Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine

Vaccines
2024-08 | Journal article | Author
Contributors: Jiaqi Wang; Pengfei Jin; Hui Jin; Qiang Wang; Fengcai Zhu; Jingxin Li
Source: check_circle
Multidisciplinary Digital Publishing Institute

Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial

Vaccines
2024-06 | Journal article | Author
Contributors: xu han; Mingwei Wei; Xiuyu Zheng; Peng Wan; Jie Tang; Lu Zhang; Shupeng Zhang; Hanchi Zhou; Jiayu Lu; Li Zhou et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Peer review (15 reviews for 10 publications/grants)

Review activity for BMC medicine (1)
Review activity for EBioMedicine. (1)
Review activity for EClinicalMedicine. (2)
Review activity for Infectious diseases and therapy. (3)
Review activity for Nature medicine. (1)
Review activity for Signal transduction and targeted therapy. (1)
Review activity for The Journal of infection. (1)
Review activity for The Lancet regional health. (3)
Review activity for The Lancet regional health. (1)
Review activity for The lancet. (1)